TH MEDICAL-B (02697) won the bid for the multi-organ multi-sensor ambient temperature perfusion system for the Yunnan Agricultural University research procurement project.
True Health Medical-B (02697) announces that the company has participated in the procurement project for research equipment for the Yunnan Agricultural Universitys Key Laboratory of Gene Editing and Xenogeneic Organ Transplantation for Small Pigs in Yunnan Province, Project No. 2026-73 (Project Number: YNGH[2026]-0626) (the Project), and has recently received notification of the projects transaction results.
TH MEDICAL-B (02697) announced that the company has participated in the procurement project for scientific research equipment of the Key Laboratory of Gene Editing and Xenogeneic Organ Transplantation of Yunnan Agricultural University, project number 2026-73 (project code: YNGH[2026]-0626) (the project), and has recently received notification of the projects tender results.
Accordingly, the company has been officially confirmed as the successful supplier for the project, which involves the procurement of one set of a multi-organ, multi-sensor, room-temperature perfusion system with an integrated respirator, with a total transaction amount of RMB 2.8 million (the transaction). The purchaser of the project is Yunnan Agricultural University, and the project serves the research on room-temperature cross-perfusion of xenogeneic multi-organs.
The board of directors believes that this transaction reflects the market's recognition of the group's products and technical capabilities, and anticipates that it will help enhance the group's market influence and business expansion capabilities in the field of scientific research medical equipment.
Related Articles

MODERN DENTAL (03600) has cancelled 636,000 repurchased shares.

ORIENTAL EXPL (00430) issues a profit warning, expecting that integrated profit attributable to shareholders for the first half of the year will decrease to approximately HK$3 million to HK$3.2 million.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.
MODERN DENTAL (03600) has cancelled 636,000 repurchased shares.

ORIENTAL EXPL (00430) issues a profit warning, expecting that integrated profit attributable to shareholders for the first half of the year will decrease to approximately HK$3 million to HK$3.2 million.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.

RECOMMEND





